Latest filing published 21 Dec 2023 for Organicell Regenerative Medicine, Inc., €4,983.
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Harry L. Leider is a declared insider at 2 companies (senior executive); the most frequent names are Zeo ScientifiX, Inc. and Gelesis Holdings, Inc. In total, 8 filings cover trades dated from 6 May 2022 to 19 December 2023.
In open-market terms, that means 4 purchases worth €64k on one side and 1 sale worth €6,317 on the other. On balance, insiders were net buyers of €58k. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Other entries cover 3 share grants. In 2023 alone, the filings show 4 purchases and 1 sale.
Half of the purchases are above €4,792 and half below. Of 3 purchases, 3 formed part of a group of insiders buying within 30 days of each other. Purchases made close together by different insiders form what is called a cluster.
The record was last updated on 21 December 2023 with an open-market purchase (€4,601) in Zeo ScientifiX, Inc. Typically, a trade is published a median of 3 days after it takes place. Section 16 rules allow two business days to file each Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations